A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:March 27, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:March 27, 2024Recruiting
Condition(s):Advanced Malignant Glioma; Anaplastic Astrocytomas; Glioblastoma MultiformeLast Updated:April 15, 2016Completed
Condition(s):HypercholesterolemiaLast Updated:September 22, 2020Completed
Condition(s):Healthy SubjectsLast Updated:November 1, 2018Completed
Condition(s):Solid TumorsLast Updated:August 14, 2023Completed
Condition(s):Head and Neck Squamous Cell Carcinoma; Melanoma Excluding Uveal Melanoma; Non-small Cell Lung Cancer, Squamous or Non-squamous; Urothelial Carcinoma; Renal Cell Carcinoma, Clear Cell; Castration-resistant Prostate Cancer; Ovarian Cancer, Epithelial; TNBC – Triple-Negative Breast Cancer; Colorectal CancerLast Updated:November 14, 2023Recruiting
Condition(s):Community-acquired Pneumonia; Bacterial PneumoniaLast Updated:March 8, 2024Recruiting
Condition(s):LeukaemiaLast Updated:May 24, 2022Terminated
Condition(s):Healthy VolunteerLast Updated:December 24, 2019Completed
Condition(s):ER+ HER2- Advanced Breast Cancer; High-grade Serous Ovarian Cancer (HGSOC)Last Updated:March 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.